Corporate calendar for Lexeo Therapeutics, Inc. Common Stock (LXEO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $144M | |
| 2026-09-14 | $898M |
Price
| Price | $4.16 |
| Market Cap | $327M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AMRN · CAPR · CTNM · DBVT · KYTX · LRMR · MREO
Explore sector: Healthcare · Biotechnology
More sections of LXEO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks